• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衔接蛋白介导前列腺癌细胞中 CXCR4 和 PI4KA 的串扰及 PI4KA 在骨肿瘤生长中的意义。

Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth.

机构信息

Department of Pathology, Wayne State University, School of Medicine, 9245 Scott Hall, 540 E. Canfield Avenue, Detroit, MI, 48201, USA.

Department of Urology, Wayne State University, School of Medicine, Detroit, MI, 48201, USA.

出版信息

Sci Rep. 2023 Nov 23;13(1):20634. doi: 10.1038/s41598-023-47633-4.

DOI:10.1038/s41598-023-47633-4
PMID:37996444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10667255/
Abstract

The chemokine receptor, CXCR4 signaling regulates cell growth, invasion, and metastasis to the bone-marrow niche in prostate cancer (PCa). Previously, we established that CXCR4 interacts with phosphatidylinositol 4-kinase IIIα (PI4KIIIα encoded by PI4KA) through its adaptor proteins and PI4KA overexpressed in the PCa metastasis. To further characterize how the CXCR4-PI4KIIIα axis promotes PCa metastasis, here we identify CXCR4 binds to PI4KIIIα adaptor proteins TTC7 and this interaction induce plasma membrane PI4P production in prostate cancer cells. Inhibiting PI4KIIIα or TTC7 reduces plasma membrane PI4P production, cellular invasion, and bone tumor growth. Using metastatic biopsy sequencing, we found PI4KA expression in tumors correlated with overall survival and contributes to immunosuppressive bone tumor microenvironment through preferentially enriching non-activated and immunosuppressive macrophage populations. Altogether we have characterized the chemokine signaling axis through CXCR4-PI4KIIIα interaction contributing to the growth of prostate cancer bone metastasis.

摘要

趋化因子受体 CXCR4 信号通路调节前列腺癌(PCa)细胞的生长、侵袭和向骨髓龛转移。此前,我们通过其衔接蛋白证实了 CXCR4 与磷酸肌醇 4-激酶 IIIα(PI4KA 编码)相互作用,并且在 PCa 转移中过表达 PI4KA。为了进一步研究 CXCR4-PI4KIIIα 轴如何促进 PCa 转移,我们发现 CXCR4 与 PI4KIIIα 衔接蛋白 TTC7 结合,这种相互作用诱导前列腺癌细胞的质膜 PI4P 产生。抑制 PI4KIIIα 或 TTC7 可减少质膜 PI4P 的产生、细胞侵袭和骨肿瘤生长。通过转移性活检测序,我们发现肿瘤中 PI4KA 的表达与总生存率相关,并通过优先富集非激活和免疫抑制的巨噬细胞群促进免疫抑制性骨肿瘤微环境。总的来说,我们通过 CXCR4-PI4KIIIα 相互作用描述了趋化因子信号轴,该信号轴有助于前列腺癌骨转移的生长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2db5/10667255/defe713a6877/41598_2023_47633_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2db5/10667255/ef67c7770324/41598_2023_47633_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2db5/10667255/0fb574dc464d/41598_2023_47633_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2db5/10667255/ce1813a03fc2/41598_2023_47633_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2db5/10667255/328c499be96f/41598_2023_47633_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2db5/10667255/9e1f018520f6/41598_2023_47633_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2db5/10667255/defe713a6877/41598_2023_47633_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2db5/10667255/ef67c7770324/41598_2023_47633_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2db5/10667255/0fb574dc464d/41598_2023_47633_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2db5/10667255/ce1813a03fc2/41598_2023_47633_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2db5/10667255/328c499be96f/41598_2023_47633_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2db5/10667255/9e1f018520f6/41598_2023_47633_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2db5/10667255/defe713a6877/41598_2023_47633_Fig6_HTML.jpg

相似文献

1
Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth.衔接蛋白介导前列腺癌细胞中 CXCR4 和 PI4KA 的串扰及 PI4KA 在骨肿瘤生长中的意义。
Sci Rep. 2023 Nov 23;13(1):20634. doi: 10.1038/s41598-023-47633-4.
2
Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth.衔接蛋白介导前列腺癌细胞中CXCR4与PI4KA的相互作用以及PI4KA在骨肿瘤生长中的意义。
Res Sq. 2023 Feb 23:rs.3.rs-2590830. doi: 10.21203/rs.3.rs-2590830/v1.
3
A novel cross-talk between CXCR4 and PI4KIIIα in prostate cancer cells.前列腺癌细胞中 CXCR4 和 PI4KIIIα 之间的新型串扰。
Oncogene. 2019 Jan;38(3):332-344. doi: 10.1038/s41388-018-0448-0. Epub 2018 Aug 15.
4
Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis.前列腺癌骨转移中CXCL12/CXCR4信号通路的药理学靶向治疗
Mol Cancer. 2016 Nov 3;15(1):68. doi: 10.1186/s12943-016-0552-0.
5
PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling.PTEN 缺失介导的 Akt 激活通过 CXCL12/CXCR4 信号促进前列腺肿瘤生长和转移。
Mol Cancer. 2013 Jul 31;12(1):85. doi: 10.1186/1476-4598-12-85.
6
CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone.CXCL12/CXCR4在前列腺癌细胞的脂筏中反式激活HER2,并促进骨转移灶的生长。
Mol Cancer Res. 2008 Mar;6(3):446-57. doi: 10.1158/1541-7786.MCR-07-0117.
7
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.在前列腺癌临床前模型中,CXCR4的药理学抑制通过影响肿瘤生长和致瘤潜力,降低骨和软组织转移负担。
Prostate. 2015 Sep;75(12):1227-46. doi: 10.1002/pros.23007. Epub 2015 Jun 12.
8
Peroxisome proliferator‑activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis.过氧化物酶体增殖物激活受体γ激动剂罗格列酮通过抑制CXCR4/CXCL12轴来抑制前列腺癌细胞的迁移和侵袭。
Mol Med Rep. 2014 Aug;10(2):695-700. doi: 10.3892/mmr.2014.2232. Epub 2014 May 13.
9
A Novel Interaction between Chemokine and Phosphoinositide Signaling in Metastatic Prostate Cancer.趋化因子与磷酸肌醇信号在转移性前列腺癌中的新型相互作用
Med Res Arch. 2023 Jul;11(7.1). doi: 10.18103/mra.v11i7.1.4020. Epub 2023 Jul 6.
10
Prostate cancer cells preferentially home to osteoblast-rich areas in the early stages of bone metastasis: evidence from in vivo models.前列腺癌细胞在骨转移的早期阶段优先归巢到成骨细胞丰富的区域:来自体内模型的证据。
J Bone Miner Res. 2014 Dec;29(12):2688-96. doi: 10.1002/jbmr.2300.

引用本文的文献

1
From Hypoxia to Bone: Reprogramming the Prostate Cancer Metastatic Cascade.从缺氧到骨:重编程前列腺癌转移级联反应
Int J Mol Sci. 2025 Aug 1;26(15):7452. doi: 10.3390/ijms26157452.
2
Phosphoinositide kinases in cancer: from molecular mechanisms to therapeutic opportunities.癌症中的磷酸肌醇激酶:从分子机制到治疗机遇
Nat Rev Cancer. 2025 Apr 3. doi: 10.1038/s41568-025-00810-1.
3
Targeting the tumour cell surface in advanced prostate cancer.靶向晚期前列腺癌的肿瘤细胞表面

本文引用的文献

1
Components of the phosphatidylserine endoplasmic reticulum to plasma membrane transport mechanism as targets for KRAS inhibition in pancreatic cancer.磷脂酰丝氨酸内质网到质膜转运机制的组成部分作为胰腺癌中 KRAS 抑制的靶点。
Proc Natl Acad Sci U S A. 2021 Dec 21;118(51). doi: 10.1073/pnas.2114126118.
2
Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity.致癌性 KRAS 依赖于 EFR3A-PI4KA 信号轴来发挥强大的肿瘤发生活性。
Nat Commun. 2021 Sep 9;12(1):5248. doi: 10.1038/s41467-021-25523-5.
3
How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer.
Nat Rev Urol. 2025 Apr 1. doi: 10.1038/s41585-025-01014-w.
4
Molecular mechanisms and targeted therapy for the metastasis of prostate cancer to the bones (Review).前列腺癌骨转移的分子机制及靶向治疗(综述)。
Int J Oncol. 2024 Nov;65(5). doi: 10.3892/ijo.2024.5692. Epub 2024 Sep 20.
5
A Plethora of Functions Condensed into Tiny Phospholipids: The Story of PI4P and PI(4,5)P.众多功能浓缩于微小的磷脂中:PI4P 和 PI(4,5)P 的故事。
Cells. 2023 May 17;12(10):1411. doi: 10.3390/cells12101411.
如何提高转移性前列腺癌的冷免疫微环境的温度。
Prostate Cancer Prostatic Dis. 2021 Sep;24(3):697-717. doi: 10.1038/s41391-021-00340-5. Epub 2021 Apr 5.
4
Profiling Cell Type Abundance and Expression in Bulk Tissues with CIBERSORTx.使用 CIBERSORTx 分析批量组织中的细胞类型丰度和表达。
Methods Mol Biol. 2020;2117:135-157. doi: 10.1007/978-1-0716-0301-7_7.
5
Determining cell type abundance and expression from bulk tissues with digital cytometry.利用数字细胞术从组织样本中测定细胞类型丰度和表达。
Nat Biotechnol. 2019 Jul;37(7):773-782. doi: 10.1038/s41587-019-0114-2. Epub 2019 May 6.
6
A novel cross-talk between CXCR4 and PI4KIIIα in prostate cancer cells.前列腺癌细胞中 CXCR4 和 PI4KIIIα 之间的新型串扰。
Oncogene. 2019 Jan;38(3):332-344. doi: 10.1038/s41388-018-0448-0. Epub 2018 Aug 15.
7
A Unidirectional Transition from Migratory to Perivascular Macrophage Is Required for Tumor Cell Intravasation.肿瘤细胞浸润需要从迁移型巨噬细胞向血管周巨噬细胞的单向转变。
Cell Rep. 2018 May 1;23(5):1239-1248. doi: 10.1016/j.celrep.2018.04.007.
8
Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis.前列腺癌骨转移中CXCL12/CXCR4信号通路的药理学靶向治疗
Mol Cancer. 2016 Nov 3;15(1):68. doi: 10.1186/s12943-016-0552-0.
9
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.去势抵抗性神经内分泌前列腺癌的不同克隆进化
Nat Med. 2016 Mar;22(3):298-305. doi: 10.1038/nm.4045. Epub 2016 Feb 8.
10
The leukodystrophy protein FAM126A (hyccin) regulates PtdIns(4)P synthesis at the plasma membrane.脑白质营养不良蛋白FAM126A(hyccin)调节质膜上磷脂酰肌醇-4-磷酸(PtdIns(4)P)的合成。
Nat Cell Biol. 2016 Jan;18(1):132-8. doi: 10.1038/ncb3271. Epub 2015 Nov 16.